Universe Pharmaceuticals INC (UPC)
USD 0.68
(-0.8%)
USD 0.68
(-0.8%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 32.3 Million | 40.14 Million | 47.98 Million | 30.7 Million | 33.22 Million | 28.51 Million |
| Cost of Revenue | 22.23 Million | 18.25 Million | 22.65 Million | 16.61 Million | 19.82 Million | 15.1 Million |
| Gross Profit | 10.07 Million | 21.89 Million | 25.32 Million | 14.09 Million | 13.4 Million | 13.4 Million |
| Operating Expenses | 13.84 Million | 28.91 Million | 11.73 Million | 3.74 Million | 3.35 Million | 3.64 Million |
| Selling, General and Administrative Expenses | 9 Million | 20.83 Million | 6.27 Million | 2.79 Million | 2.29 Million | 2.38 Million |
| Research and Development Expenses | 4.85 Million | 7.64 Million | 5.46 Million | 583.12 Thousand | 618.43 Thousand | 789.38 Thousand |
| Other Expenses | -17.53 Thousand | 430.3 Thousand | -80.43 Thousand | 365.76 Thousand | 445.77 Thousand | 5014.00 |
| Cost and Expenses | 35.83 Million | 47.16 Million | 34.39 Million | 20.35 Million | 23.17 Million | 18.75 Million |
| Operating Income | -3.52 Million | -7.01 Million | 13.59 Million | 10.25 Million | 9.75 Million | 9.65 Million |
| Interest Expense | 156.78 Thousand | 162.4 Thousand | 101.6 Thousand | 123.76 Thousand | 129.26 Thousand | 164.92 Thousand |
| Income Tax Expense | 2.31 Million | 752.41 Thousand | 2.35 Million | 2.54 Million | 2.1 Million | 1.91 Million |
| Earnings before Tax | -3.84 Million | -7.98 Million | 13.67 Million | 10.1 Million | 9.65 Million | 9.51 Million |
| Net Income | -6.16 Million | -8.73 Million | 11.31 Million | 7.55 Million | 7.55 Million | 7.6 Million |
| Earnings Per Share Basic | -1.70 | -2.41 | 3.12 | 2.06 | 2.05 | 0.36 |
| Earnings Per Share Diluted | -1.70 | -2.41 | 3.12 | 2.06 | 2.05 | 0.36 |
| Weighted Average Shares Outstanding | 3.62 Million | 3.62 Million | 3.62 Million | 3.67 Million | 3.67 Million | 21 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.62 Million | 3.62 Million | 3.62 Million | 3.67 Million | 3.67 Million | 21 Million |
| Gross Margin | 0.31 | 0.55 | 0.53 | 0.46 | 0.40 | 0.47 |
| EBIT Margin | -0.10 | -0.16 | 0.29 | 0.35 | 0.32 | 0.36 |
| Profit Margin | -0.19 | -0.22 | 0.24 | 0.25 | 0.23 | 0.27 |
| EBITDA | -3.21 Million | -7.32 Million | 14.19 Million | 10.61 Million | 10.17 Million | 10.11 Million |
| Earnings Before Tax Margin | -0.11 | -0.17 | 0.28 | 0.33 | 0.29 | 0.34 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 12.88 Million | 13.84 Million | 32.3 Million | 18.46 Million | 40.14 Million | 15.94 Million |
| Cost of Revenue | 9.63 Million | 9.77 Million | 21.99 Million | 12.45 Million | 18.25 Million | 7.88 Million |
| Gross Profit | 3.24 Million | 4.06 Million | 10.31 Million | 6.01 Million | 21.89 Million | 8.05 Million |
| Operating Expenses | 4.98 Million | 7.73 Million | 14.28 Million | 5.86 Million | 28.91 Million | 18.19 Million |
| Selling, General and Administrative Expenses | 4.85 Million | 5.05 Million | - | 3.55 Million | - | 10.57 Million |
| Research and Development Expenses | 74.7 Thousand | 2.57 Million | - | 2.24 Million | - | 7.48 Million |
| Other Expenses | -57.59 Thousand | -110.58 Thousand | -235.61 Thousand | -68.6 Thousand | 430.3 Thousand | -128.34 Thousand |
| Cost and Expenses | 14.62 Million | 17.51 Million | 36.27 Million | 18.31 Million | 47.16 Million | 26.08 Million |
| Operating Income | -1.74 Million | -3.67 Million | -3.52 Million | 149.25 Thousand | -7.01 Million | -10.14 Million |
| Interest Expense | 136.61 Thousand | 82.21 Thousand | 156.78 Thousand | 74.56 Thousand | 162.4 Thousand | 74.01 Thousand |
| Income Tax Expense | 665.14 Thousand | 1.33 Million | 2.31 Million | 974.35 Thousand | 752.41 Thousand | -825.8 Thousand |
| Earnings before Tax | -12.43 Million | -4.13 Million | -3.84 Million | 258.93 Thousand | -7.98 Million | -11.33 Million |
| Net Income | -13.1 Million | -5.44 Million | -6.16 Million | -715.42 Thousand | -8.73 Million | -10.46 Million |
| Earnings Per Share Basic | -3.59 | -1.50 | - | -0.20 | - | -2.89 |
| Earnings Per Share Diluted | -3.59 | -1.50 | - | -0.20 | - | -2.89 |
| Weighted Average Shares Outstanding | 3.64 Million | 3.62 Million | 3.62 Million | 3.62 Million | 3.62 Million | 3.62 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.64 Million | 3.62 Million | 3.62 Million | 3.62 Million | 3.62 Million | 3.62 Million |
| Gross Margin | 0.25 | 0.29 | 0.32 | 0.33 | 0.55 | 0.51 |
| EBIT Margin | -0.94 | -0.25 | - | 0.02 | - | -0.62 |
| Profit Margin | -1.02 | -0.39 | -0.19 | -0.04 | -0.22 | -0.66 |
| EBITDA | -12.05 Million | -3.42 Million | - | 407.03 Thousand | - | -9.89 Million |
| Earnings Before Tax Margin | -0.14 | -0.27 | -0.11 | 0.01 | -0.17 | -0.64 |
GDSI
PDGR3
GLA1V
4123
1580
VLS